Item 9 Labs CorpChange company Symbol lookupSelect an option...INLB Item 9 Labs CorpGLNG Golar LNG LtdDH Definitive Healthcare CorpPLMIU Plum Acquisition I CorpTSLA Tesla IncAPCX AppTech Payments CorpGP GreenPower Motor Company IncRIOT Riot Blockchain IncPSB-Z PS Business Parks IncGLNCY Glencore PLCGo
Change company Symbol lookup
Select an option...
INLB Item 9 Labs Corp
GLNG Golar LNG Ltd
DH Definitive Healthcare Corp
PLMIU Plum Acquisition I Corp
TSLA Tesla Inc
APCX AppTech Payments Corp
GP GreenPower Motor Company Inc
RIOT Riot Blockchain Inc
PSB-Z PS Business Parks Inc
GLNCY Glencore PLC
Health Care : Pharmaceuticals |
Company profileItem 9 Labs Corp is a vertically integrated cannabis operator and dispensary franchisor delivering products from its large-scale cultivation and production facilities in the United States. The Company produces cannabis and cannabis-related products and offers approximately 75 active cannabis strains and more than 150 differentiated cannabis vape products as well as premium concentrates and Orion vape technologies. The Company's Item 9 Labs brand specializes in select products and user experience across several cannabis categories. The Company also offers a dispensary franchise model through the national Unity Rd. retail brand. Item 9 Labs cultivates elevated mainstream cannabis flower, vape cartridges, concentrates and Apollo & Orion vape technologies. The Company’s products are available to consumers through licensed dispensaries in Arizona. Its products are carried in more than 70 dispensaries throughout the state of Arizona.
|
|
|
|
| |
| Latest Earnings Met Consensus (Q2 ending 03/2022) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q2 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced May 16, 2022 | -$0.04 | Q2 Estimate range of 1 analyst | -$0.03 to -$0.03 | Q3 Earnings will announce | (Unconfirmed) August 15, 2022 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
INLB's fiscal year ends in September
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.